Nanoviricides (NNVC) Amortizatization of Intangibles (2011 - 2019)
Nanoviricides (NNVC) posted Amortizatization of Intangibles of $2068.0 for Q1 2019, little changed sequentially from $2067.0 in Q4 2018, and little changed YoY from $2067.0 in Q1 2018.
Nanoviricides (NNVC) Amortizatization of Intangibles (2011 - 2019) Analysis & Trends
Nanoviricides has reported Amortizatization of Intangibles for 9 years, with the latest figure at $2068.0 in Q1 2019.
- Quarterly Amortizatization of Intangibles changed 0.05% year-over-year to $2068.0 in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $8271.0 (changed 0.01% YoY) and the FY2018 annual result came in at $8269.0, changed 0.0% from the prior year.
- Amortizatization of Intangibles steadied at $2068.0 in Q1 2019 per NNVC's latest filing, from $2067.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $2069.0 in Q3 2018 and troughed at $2067.0 in Q1 2015.
- A 5-year average of $2067.4 and a median of $2067.0 in 2015 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2015 and 2017: Amortizatization of Intangibles slipped 5.79% in 2015, then grew 0.05% in 2017.
- Over 5 years, Amortizatization of Intangibles stood at $2067.0 in 2015, then changed by 0.0% to $2067.0 in 2016, then changed by 0.0% to $2067.0 in 2017, then changed by 0.0% to $2067.0 in 2018, then increased by 0.05% to $2068.0 in 2019.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $2068.0, $2067.0, and $2069.0 for Q1 2019, Q4 2018, and Q3 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Nanoviricides | 28.74 Mn | 25.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 2,068.00 |
| Mar 31, 2019 | 2,068.00 |
| Dec 31, 2018 | 2,067.00 |
| Dec 31, 2018 | 2,067.00 |
| Sep 30, 2018 | 2,069.00 |
| Sep 30, 2018 | 2,069.00 |
| Jun 30, 2018 | 2,067.00 |
| Jun 30, 2018 | 2,067.00 |
| Mar 31, 2018 | 2,067.00 |
| Mar 31, 2018 | 2,067.00 |
| Dec 31, 2017 | 2,067.00 |
| Dec 31, 2017 | 2,067.00 |
| Sep 30, 2017 | 2,068.00 |
| Sep 30, 2017 | 2,068.00 |
| Jun 30, 2017 | 2,068.00 |
| Jun 30, 2017 | 2,068.00 |
| Mar 31, 2017 | 2,067.00 |
| Mar 31, 2017 | 2,067.00 |
| Dec 31, 2016 | 2,067.00 |
| Dec 31, 2016 | 2,067.00 |